Obesity is a major growing health concern. Currently, 40% of the world’s population is considered overweight or obese, with the rate expected to hit 50% by 2035. Despite this trend, there is a growing body of evidence to suggest that providers spend less time, offer less education, and deprioritize building a rapport with these groups. Patients with obesity are frequently subjected to unsolicited advice, with their weight tending to drive medical conversations even when they seek treatment for an unrelated issue. Ensuring diversity, equity, and inclusion across our clinical trial sites is a core focus for the Velocity team. It is part of our three-year commitment to working towards 1:1 patient enrollment to match population demographics. Nadege Gunn, MD, CPI, is a principal investigator at Velocity’s site in Waco, Texas, who has been instrumental in building processes and protocols that are inclusive of the community living with obesity. She is board certified in obesity medicine, and is a leader of Velocity’s metabolic dysfunction-associated steatohepatitis (MASH) CARE Council. Hear from Dr. Gunn and discover how her work is driving equity and improving outcomes for all in the article below. #HealthcareEquity #ClinicalResearch #ObesityAwareness #InclusiveResearch #VelocityCares
Velocity Clinical Research, Inc.’s Post
More Relevant Posts
-
Hello my UK LinkedIn connections! Check out: #Obesity in 10 countries in 10 days in less than 10 minutes/day. Between July 22 and July 31 MYND Therapeutics Inc. will be publishing daily graphs, facts, stories, videos about the lack of access to obesity healthcare, the inadequate delivery of obesity healthcare, the challenges with weight bias, equity and inclusion, the high prices and lack of affordability of therapy, drugs and bariatric surgery, and more. But we will also share science-based solutions like therapy, meds and bariatric surgery and organisations that are here to help. Today is about obesity in the UK 🇬🇧. Tomorrow is about obesity in Ireland 🇮🇪 Population: 67 million people People with overweight and obese: 64% of the adult population (18 years old+) At risk of: 200+ comorbidities Obesity experts: No data Annual spent on obesity related diseases/year by NHS: 6.5 BP billion "Obesity is a global and complex public health concern. It is associated with reduced life expectancy and is a risk factor for a range of chronic diseases, including cardiovascular disease, type 2 diabetes, cancer, liver, and respiratory disease, and can also impact on mental health. Regular physical activity is associated with a reduced risk of diabetes, obesity, osteoporosis, colon and breast cancer, and improved mental health. In older adults, physical activity is associated with increased functional capacities. Inactivity is doing less than 30 moderate intensity equivalent (MIE) minutes per week. Being physically active is doing at least 150 MIE minutes physical activity per week." - Source: GOV.UK, May 2024 Much of NHS in #England "does not take obesity seriously enough" - The Guardian https://lnkd.in/gn-Ad634 Obese patients "being weight-shamed by doctors and nurses" - The Guardian https://lnkd.in/gX7UFKQv Should we make obese people pay for NHS treatment? - Good Morning Britain https://lnkd.in/gWr48aQb Looking for a solution or resource? Try the digital obesity care program #MYNDSET (Download on the App Store in the UK starting August 1st) : https://lnkd.in/gMfZ4_DE Ask your doctor if #Ozempic #Wegovy #Mounjaro #Zepbound or bariatric surgery are right for you. Jon Wilks Laetitia MacDougall Felice L. Ivana Poparic, PhD Jason Halford Yulia Lurye, MD Fiorinta Lekkai Dr Laura Falvey Dr Kristina Curtis Mark Stimpfig Gillian Galway Euan Woodward Vijay Barathan, MD Sorina Mihaila Grace Williams Sam Muscroft Paul Newton George Edwards Anna King Dr Dolly van Tulleken Junaid Bajwa Silvia Cerolini Nick Rosa, FRSA Dr Morgaine Gaye Tony Young Andrew Gregory #UnitedKingdom #Scotland #Wales #NorthernIreland #obesity #weightloss #weightmanagement #behaviourtherapy #GLP1 #bariatricsurgery #food #UPF #nutrition #access #equity #outcomes
To view or add a comment, sign in
-
-
Racial & Gender Equity in a Skewed Medical Paradigm During my pharmacy school days at the University of California San Francisco, we were taught most pharmaceutical studies were carried out using white male subjects, age 18 to 60, with an average 70 kg in weight, and for the most part, regardless of race and sex, dose adjustment primarily focuses on pediatric or geriatric populations then kidney and liver functions. As someone who also studied Traditional Chinese Medicine & Western Herbs, it simply makes sense for me to recommend complementary approaches, which certainly include sex and race adjustment in dosing, frequency, and natural alternatives. The western medical paradigm is to me often passive and patriachical that render patients disempowered. The notion that our bodies have been for millennial working alongside with complementary treatments inspired by our native environments are mostly disregarded. This is why we pay little attention to food selection, spiritual and emotional integrity, and the contribution of energy and lifestyle adjustments to our daily healing rountines. Fundamentally, we are all being put in a box that emulates a white male aged between 18-60, which estimates to be between 3-6% of the world population. These socioeconomic factors need to be addressed in the making of public policies. Estimation of the world population of white males between the ages of 18 to 60 is consulted from: 1. United Nations Department of Economic and Social Affairs (UN DESA)- UN World Population Prospects https://lnkd.in/gyi3n2XA 2. U.S. Census Bureau- https://www.census.gov/ 3. Eurostat Population and social conditions- https://lnkd.in/gEjpMeUp 4. Statistics Canada Population and demography- https://lnkd.in/g-9jBvw8 5. Australian Bureau of Statistics (ABS) Population- https://lnkd.in/g3B9_HwJ 6. Office for National Statistics (ONS) in the UK Population- https://lnkd.in/geUZ993P 7. The Pew Research Center Demographic research- https://lnkd.in/gYggBmUf #Health #Wellness #Gender #HealthEquity #Healthcare
AccendoWave - A Pain #Data Company One example: Many drugs widely prescribed to older adults, including statins for high cholesterol, were studied mostly in men, with results extrapolated to women. “It’s assumed that women’s biology doesn’t matter and that women who are premenopausal and those who are postmenopausal respond similarly,” Faubion said. “This has got to stop: The FDA has to require that clinical trial data be reported by sex and age for us to tell if drugs work the same, better, or not as well in women,” Faubion insisted. A Top 4 Global Health Equity Solution and Top 15 Global Remote Monitoring Company, AccendoWave, benchmarks objective brain wave pain data (specialty, gender, age) and has nine #pain databases: Emergency Department, Maternal Health, Oncology, MSK, Medical Surgical, ICU, #Women, Adults, #Seniors to eliminate bias, improve outcomes and reduce health care costs. If desired, AccendoWave can also create customized pain databases for partners that can be accessed on the Datavant platform. https://lnkd.in/gdfAHzQM
Older Women Are Different Than Older Men. Their Health Is Woefully Understudied. - KFF Health News
https://kffhealthnews.org
To view or add a comment, sign in
-
AccendoWave - A #Pain Data Company TAKEAWAYS... 12 #health systems across the country will create a network to develop and test now programs aimed at tackling the nation's high mortality rate.The #maternal death rate peaked in 2021, with 1,200 deaths, or roughly 33 per every 100,000 live births, one of the highest rates among developed nations. #1 compliant - #pain isn't believed Health Equity Solution and Top 50 Remote Monitoring Company, AccendoWave, benchmarks objective #brain wave pain data (specialty, gender, age) and has nine pain #databases: Emergency Department, #Maternal Health, Oncology, MSK, Medical Surgical, ICU, #Women, Adults, Seniors to eliminate bias, improve outcomes and reduce health care costs. If desired, AccendoWave can also create customized pain databases for partners that can be accessed on the Datavant platform.
NIH Launches Maternal Health Research Centers of Excellence Program
healthleadersmedia.com
To view or add a comment, sign in
-
"More than 30 years ago, Congress directed the National Institutes of Health to include as many women as men in clinical trials. But while some progress has been made, equity remains elusive. And that’s dangerous for women. “Since 2000, women in the United States have reported total adverse events from approved medicines 52% more frequently than men, and serious or fatal events 36% more frequently,” research firm McKinsey & Company said in a report released in January." https://lnkd.in/eWCa6riG #heartdisease #statins #cardiovasculardisease #cvd #pad #hypertension #diabetes #familyhx #clinicaltrials #research #data #patients #women #minorities #healthcare #physicians #cardiologists #obgyn #primarycare #data
Why Heart Disease Research Still Favors Men
yahoo.com
To view or add a comment, sign in
-
AccendoWave - A Pain #Data Company One example: Many drugs widely prescribed to older adults, including statins for high cholesterol, were studied mostly in men, with results extrapolated to women. “It’s assumed that women’s biology doesn’t matter and that women who are premenopausal and those who are postmenopausal respond similarly,” Faubion said. “This has got to stop: The FDA has to require that clinical trial data be reported by sex and age for us to tell if drugs work the same, better, or not as well in women,” Faubion insisted. A Top 4 Global Health Equity Solution and Top 15 Global Remote Monitoring Company, AccendoWave, benchmarks objective brain wave pain data (specialty, gender, age) and has nine #pain databases: Emergency Department, Maternal Health, Oncology, MSK, Medical Surgical, ICU, #Women, Adults, #Seniors to eliminate bias, improve outcomes and reduce health care costs. If desired, AccendoWave can also create customized pain databases for partners that can be accessed on the Datavant platform. https://lnkd.in/gdfAHzQM
Older Women Are Different Than Older Men. Their Health Is Woefully Understudied. - KFF Health News
https://kffhealthnews.org
To view or add a comment, sign in
-
The ADI’s predictive capability exemplifies the critical role of SDOH in shaping health outcomes. Factors like economic stability, education, social context, and neighborhood environment profoundly influence an individual’s health and the need to search for targeted interventions. Addressing these determinants is key to closing the health equity gap. Sharing this article related to ADI, other factors and the prediction of HPQ2. Collaborative work with University of Miami. #ADI# Public Health# Health Equity# Research #Mental Health# Wellbeing #Primary care # Disease Prevention #Chronic Diseases #Sanitas #Keralty Hospital #UM https://lnkd.in/eCNzTHDe
Prediction of Positive Patient Health Questionnaire-2 Screening Using Area Deprivation Index in Primary Care - Martha Duarte, Mayra Salamanca, Juan M. Gonzalez, Roberto Roman Laporte, Karina Gattamorta, Fernando Enrique Lopez Martinez, John Clochesy, Juan Carlos Rincon Acuna, 2024
journals.sagepub.com
To view or add a comment, sign in
-
Inappropriate prescribing and polypharmacy, especially in older adults, have been associated with an increased risk of negative health outcomes. Deprescribing has been identified as one approach to address some of the problems caused by polypharmacy. AI-based technology platforms and predictive analytics can help teams analyze broad population data sets so they can concentrate their resources on patients who may benefit the most from deprescribing interventions. Discover how these innovations can help healthcare teams focus on patients who need deprescribing interventions the most. #AIinHealthcare #Deprescribing #HealthTechInnovation #medicationoptimization https://hubs.li/Q02qvP6r0
Role of Deprescribing to Reduce Polypharmacy, Interactions - Arine
blog.arine.io
To view or add a comment, sign in
A great article Velocity Clinical Research, Inc. and an important discussion to have by those in the medical field.